DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tideglusib is an investigational drug.
There have been 5 clinical trials for Tideglusib. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Alzheimer Disease, Disease, and Child Development Disorders, Pervasive. The leading clinical trial sponsors are Noscira SA, University of Toronto, and St. Michael's Hospital, Toronto.
Recent Clinical Trials for Tideglusib
|Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders||Holland Bloorview Kids Rehabilitation Hospital||Phase 2|
|Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders||McMaster University||Phase 2|
|Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders||St. Michael's Hospital, Toronto||Phase 2|